caused another crisis.
Richard remained beside her bed.
He did not open his laptop.
He did not answer company calls.
He held Luna’s hand and watched the monitors, but this time independent physicians explained every number and every medication before it entered her body.
Julia sat near the window.
She knew how fear could turn a hospital room into a world with no exits.
She also knew that grief made people easy to control.
Mercer had not needed to overpower Richard.
He had only needed to convince him that questioning the treatment would hurt his daughter.
On the second morning, Luna woke before sunrise.
Her eyes found Julia first.
“Is Mara coming?” she asked.
“No,” Julia said.
“She cannot reach you here.”
Luna looked toward her father.
Richard had fallen asleep in a chair with his hand still resting beside hers.
“She said Daddy would die if I didn’t take it.”
Julia moved closer.
“What exactly did she tell you?”
Luna swallowed.
Mara had warned her that Richard’s heart was sick from worrying.
If Luna cried, refused medicine, or told anyone about the injections, her father would collapse.
Mercer had reinforced the lie during examinations, telling Luna she needed to be brave and sleep as much as possible so her father would stay strong.
The child had believed her silence was protecting him.
When Richard woke and heard the truth, he turned away so Luna would not see him break.
Julia touched his shoulder.
“She was trying to save you,” she said.
“I was supposed to save her.”
“You can still be the father she needs now.”
That afternoon, investigators uncovered the financial structure behind Luna’s supposed treatment.
Mercer had created a private medical consulting company two years earlier.
The company owned a shell laboratory, an experimental-care agency, and a pharmaceutical distributor that existed mostly on paper.
After Luna’s mother died and the child began struggling with grief, appetite loss, and episodes of withdrawal, Richard sought help through an executive medical network.
Mercer saw an opportunity.
A routine scan had shown a harmless irregularity.
He transformed it into evidence of a rare degenerative disorder, then submitted falsified genetic results from his own shell laboratory.
Because he described the disease as rapidly fatal, Richard did not wait for ordinary referrals or insurance reviews.
He paid for immediate private care.
Every nurse, machine, test, and imported medicine passed through companies connected to Mercer.
The bills exceeded eleven million dollars.
Mara received monthly transfers disguised as consulting fees.
Her job was to administer the drugs, alter the records, and keep Luna too weak to contradict the diagnosis.
The three-month prognosis served two purposes.
It created urgency, and it gave Mercer an explanation for every new symptom his drugs produced.
Investigators believed he planned to move Luna to an offshore clinic for a final experimental procedure.
Richard had already been sent contracts requiring a payment of eighteen million dollars in advance.
Had Luna died during the transfer or treatment, her death would have appeared to confirm the disease.
The thought left Richard unable to speak.
He had signed the preliminary papers the morning Julia heard Luna whisper about the blue medicine.
One day later, and his daughter might have been taken beyond the reach of the doctors now saving her.
Mercer continued to deny
